Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,9812,000 of 20,252 grants

Active NON-SBIR/STTR RPGS
Cold-responsive gene and drug delivery-potentiated cryoimmunotherapy
NATIONAL CANCER INSTITUTE University of Maryland, College Park United States 2023 – 2028

Project Summary/Abstract Breast cancer (BC) is the 2nd leading cause of cancer-related death in American women and metastasis is the major reason of BC-related mortality. Harnessin...

$4.29M
USD
Active NON-SBIR/STTR RPGS
Investigating the therapeutic potential of a novel glutamine antagonist in KEAP1 mutant lung cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Treating KRAS mutant lung adenocarcinoma (LUAD) remains a major challenge for clinical oncology. Approximately 20% of KRAS mutant LUAD tumors carry loss-of...

$6.73M
USD
Active NON-SBIR/STTR RPGS
A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2023 – 2028

Project summary Diffuse large B cell lymphoma (DLBCL), a non-Hodgkin’s lymphoma, is the most common hematologic malignancy in the United States, and occurs in both adults and child...

$6.24M
USD
Active NON-SBIR/STTR RPGS
Cross-species development and credentialing of pediatric AML models
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

PROJECT SUMMARY: The objective of this multi-principal investigator application is to leverage the complimentary expertise of the investigators to develop and credential multiple n...

$6.65M
USD
Completed NON-SBIR/STTR RPGS
Deiminated molecules as markers for developing pancreatic cancer - A1
NATIONAL CANCER INSTITUTE Mayo Clinic Jacksonville United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) carries a dismal prognosis. Understanding the mechanisms that lead to the development of pancreatic cancer and to id...

$1.83M
USD
Completed NON-SBIR/STTR RPGS
Ligand-Induced Recruitment of CAR-T Cells to Colorectal Cancers
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2023 – 2025

PROJECT SUMMARY Among the most powerful and successful new therapies to enter the cancer clinic is CAR-T cell therapy. CAR- T cell therapy has been remarkably effective for patient...

$2.19M
USD
Completed NON-SBIR/STTR RPGS
Discovery of chemoresistant tumor subclones in pediatric liver cancers
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2023 – 2025

PROJECT SUMMARY The overall survival rate for children with high-risk liver cancer, including metastatic or relapse/refractory hepatoblastoma (HB), hepatocellular carcinoma (HCC),...

$2.25M
USD
Active NON-SBIR/STTR RPGS
ELUCIDATING THE FUNCTION OF P53-MEDIATED IL17RB REPRESSION
NATIONAL CANCER INSTITUTE St. John'S University United States 2023 – 2026

ABSTRACT In addition to its pivotal roles in regulating cell cycle arrest, apoptosis, DNA repair, and metabolism, the p53 tumor suppressor has been demonstrated to modulate innate...

$4.92M
USD
Active NON-SBIR/STTR RPGS
MR Image-Guided Drug Delivery to Cerebral Cavernous Malformations with Focused Ultrasound
NATIONAL CANCER INSTITUTE University of Virginia United States 2023 – 2028

Cerebral cavernous malformations (CCMs) are vascular lesions in the central nervous system, affecting ~0.5% of the population. CCM patients experience debilitating neurological pro...

$6.15M
USD
Active NON-SBIR/STTR RPGS
Smoking and Cancer-Related Health Disparities among Sexual and Gender Minority Adults
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT In response to PAR-22-072: Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs, this project “Smoking and...

$5.78M
USD
Active NON-SBIR/STTR RPGS
MAIT cell: microbiome crosstalk in antitumor immunity
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2028

PROJECT SUMMARY The composition of microorganisms that inhabit the gut, known as the gut microbiome, has been strongly associated with the pathogenesis of several diseases includin...

$3.57M
USD
Completed NON-SBIR/STTR RPGS
Identification of metabolic niches in African Americans with colorectal cancer
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2025

PROJECT SUMMARY In the United States, colorectal cancer (CRC) mortality is markedly higher in African-American (AA) patients than any other racial or ethnic group. Treatment option...

$1.96M
USD
Active NON-SBIR/STTR RPGS
Targeting Oncogenic PKA signaling mechanisms
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

ABSTRACT Of the 6,500 known rare diseases, only about 5% have U.S. Food and Drug Administration-approved treatments. In cancer, rare tumors account for approximately 20% of cancer...

$6.17M
USD
Completed OTHER RESEARCH-RELATED
Sidney Kimmel Cancer Center LAPS Institutional Collaboration
NATIONAL CANCER INSTITUTE Thomas Jefferson University United States 2023 – 2025

ABSTRACT The overarching goal of the Sidney Kimmel Cancer Center (SKCC) is to leverage research expertise to reduce the overall incidence, burden, and mortality from cancer in Grea...

$5.44M
USD
Active NON-SBIR/STTR RPGS
Characterizing the biochemical mechanisms of oncogenic signaling by mutant Protein Kinase A
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2028

ABSTRACT Of the 6,500 known rare diseases, only about 5% have U.S. Food and Drug Administration-approved treatments. In cancer, rare tumors account for approximately 20% of cancer...

$208.4K
USD
Active NON-SBIR/STTR RPGS
Serum biomarkers to predict immune related adverse events and benefit from single agent pembrolizumab therapy in early stage triple negative breast cancer
NATIONAL CANCER INSTITUTE Arizona State University-Tempe Campus United States 2023 – 2028

Abstract Breast cancer is the most diagnosed cancer and the second leading cause of cancer death in women in the USA. Immune checkpoint therapy (ICI) is revolutionizing the therapy...

$6.71M
USD
Completed NON-SBIR/STTR RPGS
Novel 3D DWI for Detection and Characterization of Prostate Cancer in Men with Pelvic Metal Implants
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2024

Project Summary Prostate cancer is the most common malignancy and the second leading cause of cancer-related mortality in men in the United States. The American Urological Associat...

$82K
USD
Active NON-SBIR/STTR RPGS
Novel 3D DWI for Detection and Characterization of Prostate Cancer in Men with Pelvic Metal Implants
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2026

Project Summary Prostate cancer is the most common malignancy and the second leading cause of cancer-related mortality in men in the United States. The American Urological Associat...

$1.83M
USD
Completed NON-SBIR/STTR RPGS
Enhancing Tumor Cell Immunogenicity using Improved Molecules Targeting Chromatin Remodeling
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2025

PROJECT SUMMARY Few therapies have yet to achieve durable remission of advanced stage triple negative breast cancer (TNBC). One promising approach to improve clinical outcomes is t...

$2.31M
USD
Completed NON-SBIR/STTR RPGS
Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT The central KRAS-ERK signaling axis is activated in most human pancreatic adenocarcinomas (PDAC). Attempts to target ERK1 and ERK2 signaling with non-selec...

$940K
USD